Lipid emulsions as a potential delivery system for ocular use of azithromycin

References

• Kaur IP, Kanwar M. (2002). Ocular preparations: The formulation approach. Drug Dev Ind Pharm, 28:473–93.
   PubMed Web of Science ®Google Scholar
• Chan J, Maghraby GMME, Craig JP, Alany RG. (2007). Phase transition water-in-oil microemulsions as ocular drug delivery systems: In vitro and in vivo evaluation. Int J Pharm, 328:65–71.
   PubMed Web of Science ®Google Scholar
• Alany RG, Rades T, Nicoll J, Tucker IG, Davies NM. (2006). W/O microemulsions for ocular delivery: Evaluation of ocular irritation and precorneal retention. J Control Release, 111:145–52.
   PubMed Web of Science ®Google Scholar
• Davies NM. (2000). Biopharmaceutical considerations in topical ocular drug delivery. Clin Exp Pharmacol Physiol, 27:558–62.
   PubMed Web of Science ®Google Scholar
• Levy MY, Benita S. (1989). Design and characterization of submicronized o/w emulsion of diazepam for parenteral use. Int J Pharm, 54:103–12.
   Web of Science ®Google Scholar
• Prankerd RJ, Stella VJ. (1990). The use of oil-in-water emulsion as a vehicle for parenteral drug administration. J Parenter Sci Technol, 44:139–49.
   PubMedGoogle Scholar
• Sznitowska M, Gajewska M, Janicki S, Radwanska A, Lakowski G. (2001). Bioavailability of diazepam from aqueous-organic solution, submicron emulsion and solid lipid nanoparticles after rectal administration in rabbits. Eur J Pharm Biopharm, 53:159–63.
   Google Scholar
• Marti-Mestres G, Nielloud F. (2002). Emulsions in health care applications. J Dispers Sci Technol, 23:419–39.
   Web of Science ®Google Scholar
• Tamilvanan S, Gursoy RN, Benita S. (2002). Emulsion-based delivery systems for enhanced drug absorption. Pharm Tech, 131:156–61.
   Google Scholar
• Vandamme TF. (2002). Microemulsions as ocular drug delivery systems: Recent developments and future challenges. Prog Retin Eye Res, 21:15–34.
   PubMed Web of Science ®Google Scholar
• Lallemand F, Felt-Baeyens O, Rudaz S, Hamel AR, Hubler F, Wenger R, . (2005). Conversion of cyclosporine a prodrugs in human tears vs rabbits tears. Eur J Pharm Biopharm, 59:51–6.
   PubMed Web of Science ®Google Scholar
• Sasaki H, Yamamura K, Nishida K, Nakamura J, Ichikawa M. (1996). Delivery of drugs to the eye by topical application. Prog Retin Eye Res, 15:583–620.
   Web of Science ®Google Scholar
• Zhang X, Kirsch LF. (2004). Correlation of the thermal stability of phospholipid-based emulsions and the microviscosity measurements using fluorescence polarization. Pharm Dev Technol, 9:219–27.
   PubMed Web of Science ®Google Scholar
• David DF. (2002). The significance of particle/globule-sizing measurements in the safe use of intravenous lipid emulsions. J Dispers Sci Technol, 23:679–87.
   Web of Science ®Google Scholar
• Müller RH, Schmidt S, Buttle I, Akkar A, Schmitt J, BrÖmer S. (2004). Solemuls—novel technology for the formulation of i.v. emulsions with poorly soluble drugs. Int J Pharm, 269:293–302.
   PubMed Web of Science ®Google Scholar
• Wang LX, He HB, Tang X, Shao RY, Chen DW. (2006). A less irritant norcantharidin lipid microspheres: Formulation and drug distribution. Int J Pharm, 323:161–7.
   PubMed Web of Science ®Google Scholar
• Zhang HY, Tang X, Li HY, Liu XL. (2007). A lipid microsphere vehicle for vinorelbine: Stability, safety and pharmacokinetics. Int J Pharm. doi:10.1016/j.ijpharm. 2007.07.013.
   Google Scholar
• Driscoll DF, Bacon MN, Bistrian BR. (2000). Physicochemical stability of two different types of intravenous lipid emulsion as total nutrient admixtures. J Parenter Enteral Nutr, 24:15–22.
   PubMed Web of Science ®Google Scholar
• Lee VHL, Robinson JR. (1986). Review: Topical ocular drug delivery: Recent developments and future challenges. J Ocul Pharmacol, 2:67–108.
   PubMedGoogle Scholar
• Eccleston GM. (1992). Emulsions. In: Swarbrick J, Boylan JC, eds. Encyclopedia of pharmaceutical technology. 5. New York: Marcel Dekker Inc, :137–88.
   Google Scholar
• Benita S, Levy MY. (1993). Submicron emulsions as colloidal drug carriers for intravenous administration: Comprehensive physicochemical characterization. J Pharm Sci, 82:1069–79.
   PubMed Web of Science ®Google Scholar
• Lu Y, Wang YJ, Tang X. (2008). Formulation and thermal sterile stability of a less painful clarithromycin emulsion containing vitamin E. Int J Pharm, 346:47–56.
   PubMed Web of Science ®Google Scholar
• Wehrle P, Korner D, Benita S. (1996). Sequential statistical optimization of a positively-charged submicron emulsion of miconazole. Pharm Dev Technol, 1:97–111.
   PubMedGoogle Scholar
• Lallemand F, Felt-Baeyens O, Besseghir K, Behar-Cohen F, Gurny R. (2003). Cyclosporine A delivery to the eye: A pharmaceutical challenge. Eur J Pharm Biopharm, 56:307–18.
   PubMed Web of Science ®Google Scholar
• Klang SH, Frucht-Pery J, Hoffman A, Benita S. (1994). Physicochemical characterization and acute toxicity evaluation of a positively charged submicron emulsion vehicle. J Pharm Pharmacol, 46:986–93.
   PubMed Web of Science ®Google Scholar
• Klang SH, Siganos CS, Benita S, Frucht-Pery J. (1999). Evaluation of a positively charged submicron emulsion of piroxicam on the rabbit corneum healing process following alkali burn. J Control Release, 57:19–27.
   PubMed Web of Science ®Google Scholar
• Yang SC, Benita S. (2000). Enhanced absorption and drug targeting by positively charged submicron emulsions. Drug Dev Res, 50:476–86.
   Web of Science ®Google Scholar
• Bach A, Férézou J, Frey A. (1996). Phospholipid-rich particles in commercial parenteral fat emulsions: An overview. Prog Lipid Res, 35:133–53.
   PubMed Web of Science ®Google Scholar
• Patlolla RR, Vobalaboina V. (2005). Pharmacokinetics and tissue distribution of etoposide delivered in parenteral emulsion. J Pharm Sci, 94:437–45.
   PubMed Web of Science ®Google Scholar